ArticleFrontiers in oncology2019

XIST and TSIX: Novel Cancer Immune Biomarkers in PD-L1-Overexpressing Breast Cancer Patients.

Esraa A Salama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.